We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
(-95%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-1,882.29%
Top 10 Holdings %
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$194K |
| 2 |
Rapid7
RPD
|
+$183K |
| 3 |
EFC
Ellington Financial
EFC
|
+$181K |
| 4 |
Banco Santander
SAN
|
+$159K |
| 5 |
Oscar Health
OSCR
|
+$155K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXL Service
EXLS
|
+$830K |
| 2 |
Delek US
DK
|
+$724K |
| 3 |
Broadcom
AVGO
|
+$669K |
| 4 |
Itron
ITRI
|
+$666K |
| 5 |
Brinker International
EAT
|
+$649K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.83% |
| 2 | Technology | 15.87% |
| 3 | Healthcare | 10.98% |
| 4 | Industrials | 10.86% |
| 5 | Real Estate | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
TriNet
TNET
$2.75B
| – | – |
-4,844
| Closed | -$286K |
|
|
TPH
602
DELISTED
Tri Pointe Homes
TPH
| – | – |
-6,765
| Closed | -$213K |
|
603
Transcat
TRNS
$819M
| – | – |
-4,688
| Closed | -$266K |
|
604
Travelers Companies
TRV
$81.6B
| – | – |
-864
| Closed | -$251K |
|
605
Trupanion
TRUP
$1.13B
| – | – |
-6,910
| Closed | -$258K |
|
606
Trane Technologies
TT
$104B
| – | – |
-996
| Closed | -$388K |
|
607
Toro Company
TTC
$8.88B
| – | – |
-4,300
| Closed | -$338K |
|
608
Trade Desk
TTD
$8.58B
| – | – |
-7,486
| Closed | -$284K |
|
609
TETRA Technologies
TTI
$1.35B
| – | – |
-13,151
| Closed | -$123K |
|
610
TTM Technologies
TTMI
$15.3B
| – | – |
-4,179
| Closed | -$288K |
|
611
Telus
TU
$15.9B
| – | – |
-10,228
| Closed | -$135K |
|
612
Tradeweb Markets
TW
$20.7B
| – | – |
-2,071
| Closed | -$223K |
|
613
Unity
U
$13B
| – | – |
-4,625
| Closed | -$204K |
|
614
Under Armour Class C
UA
$3.07B
| – | – |
-70,071
| Closed | -$336K |
|
615
Under Armour
UAA
$3.14B
| – | – |
-58,270
| Closed | -$290K |
|
616
Uber
UBER
$146B
| – | – |
-3,060
| Closed | -$250K |
|
617
Universal Health Services
UHS
$9.08B
| – | – |
-983
| Closed | -$214K |
|
|
UHT
618
Universal Health Realty Income Trust
UHT
$609M
| – | – |
-6,161
| Closed | -$242K |
|
619
Unisys
UIS
$256M
| – | – |
-134,338
| Closed | -$371K |
|
620
Ubiquiti
UI
$32.4B
| – | – |
-745
| Closed | -$412K |
|
621
Frontier Group Holdings
ULCC
$1.42B
| – | – |
-96,681
| Closed | -$455K |
|
622
United Natural Foods
UNFI
$3.02B
| – | – |
-8,756
| Closed | -$295K |
|
623
Upbound Group
UPBD
$1.28B
| – | – |
-11,678
| Closed | -$205K |
|
624
Vale
VALE
$60.6B
| – | – |
-26,023
| Closed | -$339K |
|
625
Vericel Corp
VCEL
$2.36B
| – | – |
-10,949
| Closed | -$394K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.
- PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
- PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
- PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
- PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
- PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
- PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
- PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.